Biocon has rallied back into a previously strong supply zone around 420–425, where price earlier faced sharp rejection and a swift drop. The current move has again stalled inside this marked “Reversal Area”, with candles showing hesitation and price stretched away from the weekly demand zone near 331, making risk‑reward attractive for a corrective downswing.
The grey box highlights the short trade zone, with stop above the recent swing high and supply, and downside open towards the prior consolidation / demand area below 390. As long as price remains below the reversal band and fails to close above 425, expectation is a mean‑reversion move lower; a clean breakout and close above the zone will invalidate the setup. This is an aggressive counter‑trend short, so position sizing and strict SL discipline are crucial.
#Biocon #BIOCON #NSEStocks #IndianStockMarket #ShareMarket #ShortTrade #ReversalTrade #SupplyZone #ResistanceZone #TechnicalAnalysis #PriceAction #SwingTrading #RiskReward #StockMarketIndia
The grey box highlights the short trade zone, with stop above the recent swing high and supply, and downside open towards the prior consolidation / demand area below 390. As long as price remains below the reversal band and fails to close above 425, expectation is a mean‑reversion move lower; a clean breakout and close above the zone will invalidate the setup. This is an aggressive counter‑trend short, so position sizing and strict SL discipline are crucial.
#Biocon #BIOCON #NSEStocks #IndianStockMarket #ShareMarket #ShortTrade #ReversalTrade #SupplyZone #ResistanceZone #TechnicalAnalysis #PriceAction #SwingTrading #RiskReward #StockMarketIndia
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.